Here, we sought to use antisense oligonucleotides (ASOs) to identify branch-specific NMD factors whose expression could be reduced to effectively impede NMD and upregulate the expression of CFTR mRNAs with nonsense codons to alleviate CF disease phenotypes. This evidence concerns the gene CFTR and cystic fibrosis.